Tag: Lichenoid drug eruption

Lichenoid drug eruption (LDE), a condition mimicking lichen planus, accounts for approximately 2.4% of all cutaneous adverse drug reactions [1.6.2, 1.6.6]. Answering **what medications are linked to lichen planus** involves identifying numerous drug classes that can trigger this inflammatory skin condition.

While rare, cutaneous adverse drug reactions to amlodipine can occur, with some case reports documenting **amlodipine associated lichen planus**. This condition, more accurately termed a lichenoid drug eruption, develops weeks to months after starting the medication and typically resolves after discontinuation.

While millions of people worldwide safely take statins to manage cholesterol, a very small number may experience adverse skin reactions. One such reaction, known as a lichenoid drug eruption, can closely mimic the symptoms of lichen planus and has been linked to statin use.

While many cases of lichen planus are idiopathic, or have no known cause, it is estimated that a significant portion can be triggered by medication, a condition known as a lichenoid drug eruption. Understanding **what medications can trigger lichen planus** is crucial for patients and clinicians to properly diagnose and manage the condition.

While cutaneous lichen planus affects less than 1% of the population, a drug-induced form known as a lichenoid drug eruption can lead to permanent hair loss [1.6.5]. Understanding **what drugs cause lichen planopilaris** is key to diagnosis and management.